The Phase 3 study with Favipiravir, sold under the brand name FabiFlu, by the company was conducted in 150 patients, it added.
Glenmark said that this was the second clinical study after the successful Favipiravir monotherapy trial earlier this year.
Rapid Response Teams at the district level will be specifically trained to assess the patients in home isolation.
Interestingly, AIIMS discouraged the use of favipiravir, an antiviral that has been approved by the Drug Controller General of India for use in mild to moderate cases.
With the launch of Faviton 400 mg, the number of tablets to be consumed have reduced to half, the statement said.
Dr Reddy's Avigan comes in a complete therapy pack of 122 tablets with a two-year shelf life.
The immunity booster consists of Vitamin C 1000 mg plus Zinc 10 mg, available in sugar free orange flavour, in a tube of 20 effervescent tablets.
RLS managing director Lohith Reddy said that Lupin, Hetero, Cipla, and Sun Pharma, have recently launched the oral pill under their own brand names at competitive prices.
Though the number of tablets required in the new regimen will be reduced by half, it's not clear how much it will cost per patient.
Zenara Pharma is already in talks with institutions and hospitals to ensure quick availability of the product and improve patient coverage by providing it at discounted rates.
'We can leverage its expertise in managing widespread community diseases like tuberculosis to proactively reach patients across India,' says Lupin President IRF Rajeev Sibal.
The third company to do so, Hetero has made Favivir available at all retail medical and hospital pharmaceutical outlets from Wednesday.
Dr AV Rama Rao, founder of AVRA Pharmaceuticals, said: “The API, if it is imported from China, costs close to $2,000 per kg, which is about Rs 1.25 lakh.
The company hopes that the easy accessibility and affordable price point of an effective treatment such as Favivent will offer Indian citizens a timely solution.
An off-patent anti-viral drug, Favipiravir, originally discovered by Fuji Pharma in Japan, has shown promise in clinical trials for treatment of COVID-19 patients, especially in mild, moderate cases